Relapsed/Refractory Aggressive B-Cell Malignancies
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Aggressive B-Cell Malignancies
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies (NCT05588440) | Oncternal Therapeutics, Inc | 2023-05-09 |
Track Relapsed/Refractory Aggressive B-Cell Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.